GlassScriptPhysician profile
Laurence R Weissman
NPI 1356373013
$2,345.70
in general payments reported to CMS, 2019-2025
15 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $212 · 2021: $250 · 2022: $290 · 2023: $397 · 2024: $215 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088 · Education: $87.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.74 |
| Education | $87.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $455.42 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $348.50 | 2021-2025 | Acthar |
| Bausch & Lomb Americas INC. | $337.64 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $284.08 | 2022-2025 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $261.90 | 2019-2025 | Simbrinza, Eysuvis, Centurion |
| Harrow Eye, LLC | $150.13 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $126.79 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.28 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $82.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $54.12 | 2019-2023 | |
| Abbvie INC. | $33.86 | 2024 | |
| Eyevance Pharmaceuticals LLC | $33.18 | 2019-2020 | |
| Eyepoint US, INC. | $23.63 | 2020 | |
| Horizon Therapeutics Plc | $19.21 | 2023 | Tepezza |
| Shire North American Group INC | $15.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Weissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.